[1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum

C86H75N5OPt — CID 168796648

IUPAC[1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum
SMILESCc1cc(N2c3ccccc3C3(c4ccc(C(C)(C)C)cc4N(c4ccccc4)c4cc(C(C)(C)C)ccc43)c3ccc(Oc4cccc(-n5c(=[Pt])n(-c6c(-c7ccccc7)cccc6-c6ccccc6)c6ccccc65)c4)cc32)ncc1-c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C86H75N5O.Pt/c1-57-50-81(87-55-70(57)60-40-42-61(43-41-60)83(2,3)4)91-75-37-21-20-36-71(75)86(72-47-44-62(84(5,6)7)51-78(72)90(64-30-18-13-19-31-64)79-52-63(85(8,9)10)45-48-73(79)86)74-49-46-67(54-80(74)91)92-66-33-24-32-65(53-66)88-56-89(77-39-23-22-38-76(77)88)82-68(58-26-14-11-15-27-58)34-25-35-69(82)59-28-16-12-17-29-59;/h11-55H,1-10H3;
InChIKeyDKVHWZBBPCAGSS-UHFFFAOYSA-N
MW1389.66 g/mol
LogP22.84
Rot. Bonds9

About [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum

[1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum (PubChem CID 168796648) has the molecular formula C86H75N5OPt and a molecular weight of 1389.66 g/mol. Its IUPAC name is [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum.

Molecular Properties

Compound Name[1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum
PubChem CID168796648
Molecular FormulaC86H75N5OPt
Molecular Weight1389.66 g/mol
Exact Mass1388.56
IUPAC Name[1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum
SMILESCc1cc(N2c3ccccc3C3(c4ccc(C(C)(C)C)cc4N(c4ccccc4)c4cc(C(C)(C)C)ccc43)c3ccc(Oc4cccc(-n5c(=[Pt])n(-c6c(-c7ccccc7)cccc6-c6ccccc6)c6ccccc65)c4)cc32)ncc1-c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C86H75N5O.Pt/c1-57-50-81(87-55-70(57)60-40-42-61(43-41-60)83(2,3)4)91-75-37-21-20-36-71(75)86(72-47-44-62(84(5,6)7)51-78(72)90(64-30-18-13-19-31-64)79-52-63(85(8,9)10)45-48-73(79)86)74-49-46-67(54-80(74)91)92-66-33-24-32-65(53-66)88-56-89(77-39-23-22-38-76(77)88)82-68(58-26-14-11-15-27-58)34-25-35-69(82)59-28-16-12-17-29-59;/h11-55H,1-10H3;
InChIKeyDKVHWZBBPCAGSS-UHFFFAOYSA-N
XLogP22.84
TPSA38.46 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms93
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001389.66
LogP ≤ 522.84
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum?
The IUPAC name of [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum (CID 168796648) is [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum.
What is the SMILES notation for [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum?
The canonical SMILES for [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum is Cc1cc(N2c3ccccc3C3(c4ccc(C(C)(C)C)cc4N(c4ccccc4)c4cc(C(C)(C)C)ccc43)c3ccc(Oc4cccc(-n5c(=[Pt])n(-c6c(-c7ccccc7)cccc6-c6ccccc6)c6ccccc65)c4)cc32)ncc1-c1ccc(C(C)(C)C)cc1.
What is the InChIKey of [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum?
The InChIKey is DKVHWZBBPCAGSS-UHFFFAOYSA-N. The full InChI is InChI=1S/C86H75N5O.Pt/c1-57-50-81(87-55-70(57)60-40-42-61(43-41-60)83(2,3)4)91-75-37-21-20-36-71(75)86(72-47-44-62(84(5,6)7)51-78(72)90(64-30-18-13-19-31-64)79-52-63(85(8,9)10)45-48-73(79)86)74-49-46-67(54-80(74)91)92-66-33-24-32-65(53-66)88-56-89(77-39-23-22-38-76(77)88)82-68(58-26-14-11-15-27-58)34-25-35-69(82)59-28-16-12-17-29-59;/h11-55H,1-10H3;.
What are the key properties of [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum?
[1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum has a molecular weight of 1389.66 g/mol, XLogP of 22.84, 9 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-[[3,6-ditert-butyl-10'-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-10-phenyl-9,9'-spirobi[acridine]-3'-yl]oxy]phenyl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum is sourced from PubChem (CID 168796648), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).